These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 12516524)

  • 41. Multiple ligands in opioid research.
    Ballet S; Pietsch M; Abell AD
    Protein Pept Lett; 2008; 15(7):668-82. PubMed ID: 18782061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The molecular structure of the opioid receptors].
    Sirakov L
    Mol Med (Sofia); 1996; 1(1):4-7. PubMed ID: 8974764
    [No Abstract]   [Full Text] [Related]  

  • 43. Molecular modeling of mu opioid receptor and receptor-ligand interaction.
    Rong SB; Zhu YC; Jiang HL; Zhao SR; Wang QM; Chi ZQ; Chen KX; Ji RY
    Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):317-22. PubMed ID: 10072913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of receptor-specific opioid peptide analogues.
    Schiller PW
    Prog Med Chem; 1991; 28():301-40. PubMed ID: 1668844
    [No Abstract]   [Full Text] [Related]  

  • 45. Cloning, sequencing, chromosomal location, and function of cDNAs encoding an opioid growth factor receptor (OGFr) in humans.
    Zagon IS; Verderame MF; Allen SS; McLaughlin PJ
    Brain Res; 2000 Feb; 856(1-2):75-83. PubMed ID: 10677613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In search of the 'bio-active conformation'--is it induced by the target cell membrane?
    Schwyzer R
    J Mol Recognit; 1995; 8(1-2):3-8. PubMed ID: 7541228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exploration of universal cysteines in the binding sites of three opioid receptor subtypes by disulfide-bonding affinity labeling with chemically activated thiol-containing dynorphin A analogs.
    Shirasu N; Kuromizu T; Nakao H; Chuman Y; Nose T; Costa T; Shimohigashi Y
    J Biochem; 1999 Jul; 126(1):254-9. PubMed ID: 10393346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dermenkephalin and deltorphin I reveal similarities within ligand-binding domains of mu- and delta-opioid receptors and an additional address subsite on the delta-receptor.
    Charpentier S; Sagan S; Delfour A; Nicolas P
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1161-8. PubMed ID: 1656944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Molecular biological study of opioid receptors--agonists selectivity and intracellular communication mechanism].
    Fukuda K
    Masui; 1997 Nov; 46 Suppl():S90-4. PubMed ID: 9508591
    [No Abstract]   [Full Text] [Related]  

  • 50. In vitro and direct in vivo testing of mixture-based combinatorial libraries for the identification of highly active and specific opiate ligands.
    Houghten RA; Dooley CT; Appel JR
    AAPS J; 2006 May; 8(2):E371-82. PubMed ID: 16796388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 100 years lock-and-key concept: are peptide keys shaped and guided to their receptors by the target cell membrane?
    Schwyzer R
    Biopolymers; 1995; 37(1):5-16. PubMed ID: 7880967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Opioid receptor oligomerization. Detection and functional characterization of interacting receptors.
    Gomes I; Filipovska J; Devi LA
    Methods Mol Med; 2003; 84():157-83. PubMed ID: 12703323
    [No Abstract]   [Full Text] [Related]  

  • 53. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
    Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
    Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conformationally restricted peptides as tools in opioid receptor studies.
    Janecka A; Kruszynski R
    Curr Med Chem; 2005; 12(4):471-81. PubMed ID: 15720255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent developments in the study of opioid receptors.
    Cox BM
    Mol Pharmacol; 2013 Apr; 83(4):723-8. PubMed ID: 23249538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Opioid receptor endocytosis and activation of MAP kinase pathway.
    Trapaidze N; Gomes I; Cvejic S; Bansinath M; Devi LA
    Brain Res Mol Brain Res; 2000 Mar; 76(2):220-8. PubMed ID: 10762697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opioid receptor binding properties of analgesic analogues of cholecystokinin octapeptide.
    Slaninova J; Knapp RJ; Wu JJ; Fang SN; Kramer T; Burks TF; Hruby VJ; Yamamura HI
    Eur J Pharmacol; 1991 Jul; 200(1):195-8. PubMed ID: 1663041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression cloning of cDNA encoding a seven-helix receptor from human placenta with affinity for opioid ligands.
    Xie GX; Miyajima A; Goldstein A
    Proc Natl Acad Sci U S A; 1992 May; 89(9):4124-8. PubMed ID: 1315051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Taxol inhibits opioid binding on T47D human breast cancer cells.
    Bakogeorgou E; Hatzoglou A; Castanas E
    Biochem Biophys Res Commun; 1997 Jun; 235(1):201-4. PubMed ID: 9196063
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular modeling of the ligand-binding domains of the NR3A and NR3B subunits of the NMDA receptor.
    Belenikin MS; Costantino G; Palyulin VA; Pellicciari R; Zefirov NS
    Dokl Biochem Biophys; 2003; 389():83-9. PubMed ID: 12856411
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.